Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.46M Sell
81,095
-8,885
-10% -$592K 2.35% 10
2026
Q1
$5.65M Buy
89,980
+172
+0.2% +$12K 2.21% 11
2025
Q4
$5.96M Sell
89,808
-45,391
-34% -$2.93M 1.67% 17
2025
Q3
$9.1M Sell
135,199
-8,900
-6% -$704K 1.92% 14
2025
Q2
$12.6M Sell
144,099
-27,564
-16% -$2.16M 2.17% 11
2025
Q1
$11.7M Buy
+171,663
New +$14M 1.78% 15

Other funds holding DXCM

2Xideas's DXCM Position: Q2 2026 in Review

2Xideas reduced its DexCom (DXCM) stake by 9.9% in Q2 2026, selling an estimated $592K and leaving 81,095 shares worth $5.46M. The position accounts for 2.35% of the portfolio, ranked #10.

2Xideas first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $12.6M in Q2 2025. 977 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • 2Xideas held 81,095 shares of DexCom worth $5.46M as of Q2 2026.
  • 2Xideas sold 8,885 DexCom shares in Q2 2026, an estimated $592K.
  • DexCom made up 2.35% of 2Xideas's portfolio in Q2 2026, its #10 holding.
  • 2Xideas first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • 2Xideas's DexCom position peaked at $12.6M in Q2 2025.
  • 977 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on 2Xideas's 13F filing for Q2 2026, filed 14 Aug 2026.